skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Fowlpox-NY-ESO-1 Vaccine (Code C48465)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Fowlpox-NY-ESO-1 Vaccine

Definition: A cancer vaccine consisting of a recombinant fowlpox virus vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen found in normal testis and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis. (NCI05)

Label: Fowlpox-NY-ESO-1 Vaccine

NCI Thesaurus Code: C48465 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1541543  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Fowlpox-NY-ESO-1 Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 428315
PDQ Open Trial Search ID 428315 (check for NCI PDQ open clinical trial info)
UMLS CUI C1541543

Other Properties:
     Name Value (qualifiers indented underneath)
code C48465
Legacy_Concept_Name Fowlpox-NY-ESO-1_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom